ABBOTT PARK, Ill., July 11, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new ...
-- Abbott's Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms -- The test helps save on ...
How important are diagnostic tests in clinical decision making? Diagnostic tests are critical as up to 60 to 70% of critical clinical decisions are influenced by diagnostic test results. It's of huge ...
According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott's new HPV ...
Receive the latest, in-depth information about Abbott’s new product launches Tune in to live webinars to hear from KOLs and current Alinity m users Visit the Exhibit Hall to learn about Abbott’s ...
The International Monetary Fund said on Friday it approved about $348.5 million in funding for the Democratic Republic of Congo after completing reviews of programs under its Extended Credit ...
Abbott announced that the US Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity s System. This new solution will bring the latest screening technology to US ...
Abbott Laboratories received FDA emergency use authorization (EUA) for its COVID-19 molecular test, which will run on the company's new Alinity m system, as well as its COVID-19 antibody blood test, ...
Abbott has received US Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results